Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families

Not Applicable

Not yet recruiting

• Conditions: Pediatric Cancer

• Registration Number: NCT07218328
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

The goal of this research study is to learn if the FoodiiS-Kids intervention is useful to parents and guardians of pediatric cancer survivors.

Detailed Description

Primary Objective:

Assess the feasibility and acceptability of the FoodiiS intervention for parents of pediatric cancer survivors (recruitment, retention, satisfaction).

Secondary Objective:

Explore the preliminary efficacy of FoodiiS to improve diet quality and cooking behaviors among parents of pediatric cancer survivor.

Study Timeline

• Status Verified: 2025-10
• Study First Submitted: 2025-10-16
• Study First Submitted QC: 2025-10-16
• Last Update Submitted: 2025-10-16
• Study First Posted: 2025-10-20
• Last Update Posted: 2025-10-20
• Study Start: 2026-04-30
• Primary Completion: 2027-07-01
• Study Completion: 2029-07-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

• Parents/guardians of school-aged (5-12 years) pediatric cancer survivors.
• Have children that are within five years of having completed active treatment.
• Self-report having internet access.
• Self-report as being able to speak and read English.
• Willing to complete study assessments.

Exclusion Criteria

• Parents of pediatric cancer survivors over 12 years of age.
• Unwilling or unable to complete study assessments.
• Self-report to not speak English.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Safety and Adverse Events (AEs)	Through study completion; an average of 1 year	Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Trial Locations

Locations (1)

The University of Texas M. D. Anderson Cancer Center; 🇺🇸 Houston, Texas, United States